Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-03-08
2009-10-27
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07608624
ABSTRACT:
The invention relates to a method of treatment of a variety of neurodegenerative diseases such as Alzheimer disease using a imidazo[1,2-a]pyrimidone derivative represented by formula (I) or a salt thereof:Wherein X, R1, R2, and n are as defined herein.
REFERENCES:
patent: 6096753 (2000-08-01), Spohr et al.
patent: 7067521 (2006-06-01), Lochead et al.
patent: WO 00/18758 (2000-04-01), None
Tatebayashi et al., Journal of Neuroscience (1999), 19(13), pp. 5245-5254.
Alonso. M. et al., GSK-3 Inhibitors: Discoveries and Developments, Current Medicinal Chemistry, 2004, vol. 11 , pp. 755-763.
Witherington, J., et al., 5-Aryl-Pyrazolo[3,4-b]Pyridlnes: Potent Inhibitors of Glycogen Synthase Kinase-3 (GSK-3), Bioorganic & Medicinal Chemistry Letters vol. 13,(2003) pp. 1577-1580.
Lochead Alistair
Marguerie Séverine
Saady Mourad
Yaiche Philippe
Gupta Balaram
Mitsubishi Pharma Corporation Tokyo
Rahmani Niloofar
Sanofi-Aventis
Seaman D. Margaret
LandOfFree
1-[alkyl], 1-[(heteroaryl)alkyl] and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-[alkyl], 1-[(heteroaryl)alkyl] and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-[alkyl], 1-[(heteroaryl)alkyl] and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4141770